Blog

Handbook of Psychotherapy and Behavior Change: Starting in March 2013 I will review one chapter a month from the Handbook of Psychotherapy and Behavior Change in addition to reviewing psychotherapy research articles. Book chapters have more restrictive copy right rules than journal articles, so I will not provide author email addresses for these chapters. If you are interested, the Handbook table of content can be viewed on Amazon.

Bohart, A.C. & Wade, A.G. (2013). The client in psychotherapy. In M. Lambert (Ed.) Bergin and Garfield’s handbook of psychotherapy and behavior change (6^th ed.), pp. 219-257. Hoboken, NJ: Wiley.

Some authors argue that client factors account for 30% of variance in outcomes. That represents a greater association to psychotherapy outcome than therapist effects and therapeutic techniques combined. In this part of the Handbook chapter on client factors, Bohart and Wade discuss client attachment. Bowlby found that attachment relationships were important and were different from other relationships. Attachment figures confer a sense of security and safety to infants that allow children to explore their environment and experience the self. Attachment patterns that develop in childhood tend to be stable throughout the lifespan, but attachment style can change with positive (i.e., psychotherapy, romantic relationships) and negative (i.e., traumatic events) experiences. Attachment security is associated with adaptive affect regulation, positive view of self and others, and reflective functioning that is related to mentalizing. Attachment anxiety is associated with maladaptive up-regulation of emotions, positive view of others but negative view of self, and reduced reflective functioning likely due to preoccupation with relationships and emotion dysregulation. Attachment avoidance is associated with maladaptive down-regulation of emotions, negative view of others and positive view of self (or negative view of others and negative view of self in the case of fearful avoidant attachment), and limited reflective functioning due to dismissing of emotions and relationships. There are also disorganized attachment states related to traumatic events. Those with attachment avoidance tend to be distrustful and less likely to seek psychotherapy. A meta-analysis by Levy and colleagues (2011) of 19 studies including 1467 clients found that attachment security was associated with good psychotherapy outcomes and attachment anxiety was negatively associated with good outcomes. No relationship was found for attachment avoidance and outcomes. Diener and Monroe (2011) conducted a separate meta analysis on attachment and therapeutic alliance which included 17 studies with 886 clients. They found that clients with secure attachments had better alliances with their therapist and those with insecure attachments (anxious or avoidant) had weaker alliances.

Practice Implications

The research is clear that client attachment style influences how clients enter therapy, engage with the therapist, and experience outcomes. Attachment style likely affects specific therapy behaviors like self-disclosure and amount of exploration. In his book Attachment and Psychotherapy, David Wallin (2007) translates attachment theory into a framework for adult psychotherapy by tailoring interventions to specific attachment styles. For example, clients with greater attachment anxiety may do better in psychotherapy when the therapist: helps with down regulation of client emotional experiences, behaves in a way that does not evoke client fears of abandonment or loss, and helps clients improve reflective functioning by encouraging a thoughtful appraisal of their behaviors. On the other hand clients with greater attachment avoidance may require a therapist who: slowly introduces the client to greater attention to emotional experiences, does not demand too much from the client in terms of closeness in therapy at the outset, and encourages reflective functioning by helping the client understand the association between defensive avoidance of affect and relationship problems.

Lambert, M. J. (2012). Helping clinicians to use and learn from research-based systems: The OQ-analyst. Psychotherapy, 49(2), 109.

One of the more interesting and clinically relevant trends in psychotherapy research and practice in the past 10 years is the emergence of research on continuous progress monitoring. Continuous progress monitoring occurs when a patient is given a standardized self report measure before a session and the results of patient functioning are fed back to the therapist. (This is distinct from a clinician asking a patient for a verbal account of how he or she is doing this week). The standardized self report assessment is often done repeatedly, sometimes before every session or every fixed number of sessions. Measures, such as the Outcome Questionnaire (OQ) for adults or youths, was specifically designed for this purpose. The OQ assesses symptoms, interpersonal functioning, and life functioning, and clients are identified as improving (i.e., on course), or at risk of deteriorating. Recently, a small meta analysis of 3 to 4 studies representing 454 to 558 clients on the effects of progress monitoring found a moderate relationship between monitoring plus feedback and client outcomes. The method is particularly effective in changing the course of outcomes for patients who are deteriorating. Large research reviews of evidence based treatments in randomized controlled trials show that about 40% to 60% of patients improve or recover from psychotherapy, 30% to 50% may not benefit, and 3% to 14% deteriorate (see my March 2013 blog). These proportions are likely less positive in everyday practice in which clients are not highly screened to meet research inclusion criteria. Unfortunately, clinicians’ views of their own client outcomes are unrealistically positive. In one survey, clinicians in routine practice reported that about 85% of their clients improved or recovered. About 90% of therapists rated themselves in the upper quartile and none rated themselves as below average (50^th percentile). Also there is serious doubt about the ability of clinicians to identify clients during the course of therapy, who ultimately deteriorate. In the paper by Lambert on the use of the Outcome Questionnaire (OQ), he reviewed several studies on continuous progress monitoring in everyday practice. Each therapist was asked to practice as they routinely do with half their usual caseload. With the other half of their caseload clients completed the OQ and the therapist received feedback before every session about patient progress. The feedback did not make a difference for clients who made steady progress (i.e., on track) from week to week. However, continuous progress monitoring did make a difference for the 20% to 30% who showed some sign of deteriorating at some point in treatment. Notifying therapists that these patients were in trouble reduced the rate of deterioration from 20.1% to 5.5%, and monitoring and feedback increased positive outcomes from 22.3% to 55.5%.

Practice Implications

Lambert reported that clinicians in these “practice as usual” studies were initially skeptical but quite surprised at the outcomes related to continuous progress monitoring. Standardized assessments appear to get around the problem of clinician over-estimation of their patients’ positive outcomes. Clinicians were able to more accurately identify clients at risk of deteriorating likely resulting in the therapist doing something different to forestall the negative consequences. Lambert argues that it is in the best interest of at-risk patients to have their symptoms, interpersonal functioning, and life functioning formally monitored throughout treatment. However, clinicians are likely to resist doing so because they believe that they are already highly successful, and even more so than the typical outcomes produced by clinical trials. Formal monitoring of client outcomes has little downside for clinicians (it is inexpensive and requires little training), and it has many upsides for clients, especially those who are at risk for deteriorating.

Author email: michael_lambert@byu.edu

Handbook of Psychotherapy and Behavior Change: Starting in March 2013 I will review one chapter a month in the Handbook of Psychotherapy and Behavior Change in addition to reviewing psychotherapy research articles. Book chapters have more restrictive copy right rules than journal articles, so I will not provide author email addresses. If you are interested, the Handbook table of content can be viewed on Amazon.

Lambert, M.J. (2013). The efficacy and effectiveness of psychotherapy. In M.J. Lambert (Ed.) Bergin and Garfield’s handbook of psychotherapy and behaviour change (6^th ed.), pp. 169-218. Hoboken, N.J.: Wiley.

An important issue for patients, therapists, and agencies is the optimal dosage of psychotherapy that is necessary to reduce impairment and improve life functioning. In this part of the Handbook chapter on Efficacy and Effectiveness of Psychotherapy, Lambert tackles the issue of the psychotherapy dose-response relationship by reviewing the existing literature. That literature tends to focus on naturalistic national (U.S.) samples of patients (often N > 6,000) receiving routine care in Health Maintenance Organizations, Employee Assistance Programs, and Community Mental Health Clinics. Outcomes tend to be assessed by patient self report, and can include symptoms, character traits, quality of life, and interpersonal functioning, among others. Lambert defines “improved” patients as those who reliably changed but still are within the dysfunctional range on a measure, and he defines “recovered” patients as those who both reliably improved and were no longer in the dysfunctional range. He concluded that on average 50% of patients who begin treatment in the dysfunctional range achieve recovery following 21 sessions of psychotherapy. On the flip side, half of patients do not achieve recovery after 21 sessions. Almost 50 sessions are necessary for 75% of patients to recover. In other words, there is a rapid rate of recovery in which half of patients recover after 21 sessions, but then the rate of recovery slows down so that it takes up to 50 sessions for an additional 25% of patients to recover. The rates of recovery also differ depending on what is measured. Symptoms (depression, anxiety, etc.) tend to recover more quickly than characterological or interpersonal problems. Further, some patients experience sudden symptom gains in therapy that are long lasting. Between 17% and 50% of patients experience the majority of their symptom improvements within 7 sessions, and these early changes accounted for 50% of total symptom gains in therapy.

Practice Implications

The question of how much therapy is enough is important for practical and theoretical reasons. Research on this topic can help patients, therapists, and agencies make decisions about treatment planning. Research suggests that a sizeable proportion of patients (50%) reliably improve after 7 sessions and a similar percentage recover after 21 sessions. However, limiting treatment to less than 20 sessions will mean that about half of patients will not achieve a substantial benefit from therapy. Session limits need to be assessed carefully depending on how the patient is doing and what outcomes are important or valued. Agencies or clinicians that firmly set limits on the number of psychotherapy sessions that are too low will have the majority of their patients showing some improvement but not recovering.

Handbook of Psychotherapy and Behavior Change: Starting in March 2013 I will review one chapter a month from the Handbook of Psychotherapy and Behavior Change in addition to reviewing psychotherapy research articles. Book chapters have more restrictive copy right rules than journal articles, so I will not provide author email addresses for these chapters. If you are interested, the Handbook table of content can be viewed on Amazon.

Forand, N.R., DeRubeis, R.J., & Amsterdam, J.D. (2013). Combining medication and psychotherapy in the treatment of major mental disorders. In M.J. Lambert (Ed.) Bergin and Garfield’s handbook of psychotherapy and behaviour change (6^th ed.), pp. 735-774. Hoboken, N.J.: Wiley.

This comprehensive chapter covers evidence for combining medication and psychotherapy for several disorders. This month I report on the section of the chapter on schizophrenia. Practice guidelines recommend antipsychotic medications as the first line treatment for Schizophrenia. However, up to 30% of individuals show an initial poor response and an additional 30% of patients continue to experience symptoms. Medication side effects can be debilitating, resulting in poor adherence and therefore reduced effectiveness. Further, Schizophrenia spectrum disorders are heterogenous in presentation and course, and so a “one size fits all” approach will not be effective for some or many. Psychotherapies can enhance the effectiveness of medications at different phases of treatment to hasten recovery or reduce medication-resistant symptoms. CBT for schizophrenia was developed to treat persistent medication-resistant positive psychotic symptoms (i.e., positive symptoms refer to delusions, hallucinations, disorganized speech and behaviour; whereas negative symptoms refer to restrictions in: emotions, thoughts, speech, and initiating goal directed behaviors). CBT focuses on reappraising the power and source of hallucinations, evaluating delusions, and addressing motivational deficits. CBT appears to be effective for chronic symptoms of schizophrenia with small to moderate effects, and these effects appear to be enduring. There is currently less and mixed evidence for CBT to speed recovery from first episode psychosis and to improve relapse rates. There is also evidence suggesting the effects of family psychoeducation to reduce relapse and to improve caregiver outcomes. However, family psychoeducation requires the participation of a caregiver, which may be a challenge that limits its utility. There is promising research on multidisciplinary rehabilitation programs that include case management, behaviour management, social skills training, social cognitive training, and cognitive remediation. There is also controversial research on providing psychological interventions alone or in a staged approach (i.e, in which earlier and less severe stages are treated with more benign interventions, and later stages are treated more aggressively with medication). However there are as yet no well-controlled clinical data to support this approach.

Practice Implications

Adjunctive psychosocial treatments appear to improve symptomatic and functional outcomes in individuals with schizophrenia spectrum disorders. CBT is best suited for treating chronic positive psychotic symptoms, but its effect on relapse prevention is equivocal. Individuals who are at risk for relapse might benefit from family psychoeducation, if the caregiver can be engaged. Multidisciplinary rehabilitation programs are a promising avenue of treatment.

Handbook of Psychotherapy and Behavior Change: Starting in March 2013 I will review one chapter a month from thenHandbook of Psychotherapy and Behavior Change in addition to reviewing psychotherapy research articles. Book chapters have more restrictive copy right rules than journal articles, so I will not provide author email addresses for these chapters. If you are interested, the Handbook table of content can be viewed on Amazon.

Burlingame, G.M., Strauss, B., & Joyce, A.S. (2013). Change mechanisms and effectiveness of small group treatments. In M.J. Lambert (Ed.) Bergin and Garfield’s handbook of psychotherapy and behaviour change (6^thed.), pp. 640-689. Hoboken, N.J.: Wiley.

Group treatments are the most common types of interventions offered in community, organizational, institutional, and hospital settings. They occur in many contexts including: outpatients, inpatients, day hospital, private practice, community health, support groups, drop-in centres, and educational organizations. Despite the extent of their application, group treatments receive relatively little research attention compared to individual psychotherapy or medication interventions. (Not to mention the pervasive and mistaken notion that group therapy is like doing individual therapy with 8-10 patients at once, or that individual therapy training is sufficient to be expert in group therapy). There are many reasons for this relatively lower amount of research, including the lack of expertise in and understanding of group practice among clinical researchers, and the substantially greater difficulty in running a clinical trial of group therapy (of the latter I have ample experience and war wounds). Nevertheless, Burlingame and colleagues summarized more than 250 studies that estimated the efficacy or effectiveness of group therapy for 12 disorders or populations. The findings indicate good or excellent evidence for the efficacy of group treatments for many disorders or patient groups (e.g., panic, social phobia, OCD, eating disorders, substance abuse, trauma related disorders, coping with breast cancer, schizophrenia, and personality disorders). There are also promising results for other disorders (e.g., mood, pain, and inpatients). Although there are substantially more studies on group CBT, most studies that compare different models (including IPT, psychodynamic, DBT, etc.) often produce equivalent outcomes. There is also lots of evidence that group therapy is as effective as individual therapy or medications for most disorders. In one U.S. study on panic disorder, group psychotherapy was the most cost effective (i.e., cost per rate of improvement) of the interventions ($246) compared to individual therapy ($565) and medications ($447). There is also research on the effects of specific characteristics of groups. For example, research on group composition (i.e., heterogenous vs homogeneous in terms of patient population or functioning) has produced mixed results, though there is emerging evidence that heterogeneous groups tend to benefit those who are lower functioning. Further, research on group cohesion (i.e., the bond between the individual and the group) which is a construct related to but distinct from alliance, is positively associated with treatment outcomes with a moderate effect size.

Practice Implications

Group treatments are as effective as individual therapy or medications, and are likely more cost effective. However group therapy is more complicated to practice and to study. Burlingame and colleagues suggest using empirically validated interventions, and ongoing assessment of client outcomes. They also suggest following the American Group Psychotherapy Association (AGPA) practice guidelines (see the Resources page on our web site), that include best practices for creating a successful group, appropriately selecting clients, preparing clients for group, evidence based interventions, and ethics issues related to group practice. Finally, Burlingame and colleagues emphasize using AGPA recommended measures and resources in developing and assessing a therapy group. These include: (1) group selection and group preparation which may involve handouts for group leaders and members about what to expect and how to get the most from group therapy; (2) assessing group processes repeatedly during group therapy using measures like the Therapeutic Factors Inventory or the Working Alliance Inventory; and (3) measuring client outcomes by using an instrument like the Outcome Questionnaire-45. Repeated measurement and feedback of processes and outcomes to the therapist may improve the group’s effectiveness.

Handbook of Psychotherapy and Behavior Change: Starting in March 2013 I will review one chapter a month the Handbook of Psychotherapy and Behavior Change in addition to reviewing psychotherapy research articles. Book chapters have more restrictive copy right rules than journal articles, so I will not provide author email addresses for these chapters. If you are interested, the Handbook table of content can be viewed on Amazon.

Forand, N.R., DeRubeis, R.J., & Amsterdam, J.D. (2013). Combining medication and psychotherapy in the treatment of major mental disorders. In M.J. Lambert (Ed.) Bergin and Garfield’s handbook of psychotherapy and behaviour change (6^th ed.), pp. 735-774. Hoboken, N.J.: Wiley.

This comprehensive chapter covers evidence for combining medication and psychotherapy for several disorders. This month I report on the section of the chapter on depression. Psychotherapy and antidepressant medications appear to have similar efficacy in short-term treatment trials, though psychotherapy has better outcomes than medication in the longer term. Psychotherapeutic treatments including Brief Dynamic Therapy (BDT), Interpersonal Psychotherapy (IPT), and Cognitive Behavioral Therapy (CBT) confer enduring benefit by preventing relapse and recurrence when compared to discontinuing medication. Antidepressant medication is modestly effective during initial short-term treatments with remission rates less than 50% and long term recurrence range from 40% to 85%. Combining medication with psychotherapy provides a small to moderate short term advantage over monotherapy of medication or psychotherapy. Combining medication and psychotherapy is more useful for when considering chronicity rather than severity of depression. The results are consistent for BDT, IPT, and for CBT.  In the longer term, efficacy of combined treatments is not better than either monotherapy. Taken together, the evidence for combined therapy for depression is modestly positive with little evidence that treatments interfere with each other (by contrast, see the March 2013 blog for findings of interference in combined therapy for anxiety disorders). Nevertheless, prolonged continuation of medication monotherapy is an added expense that is often ineffective. In fact, prolonged antidepressant medication maintenance can worsen the course of depressive illness for some, and efficacy tends to fade after 3 to 6 months of maintenance. Finally, there is emerging evidence of progressive tolerance (tachyphylaxis) or even worsening of symptoms during medication maintenance. Studies suggest that psychotherapy added to maintenance medication was associated with decreased relapse rates when compared to medication alone in the longer term.

Practice implications

Combined treatments (antidepressant medication plus psychotherapy) for major depression provide modest incremental improvements in response over monotherapy. Results of combination treatments are better, though still modest, for those with chronic depression. The evidence does not support the use of combined treatments for mild to moderate depression, unless the individual does not responds to initial monotherapy. Practitioners could consider monotherapy (i.e., psychotherapy or medication) first, followed by switching therapy or augmenting therapy for non-responders. If a patient is started on short term monotherapy of medication, practitioners may consider switching to psychotherapy for better long term relapse prevention.